Genotoxic Agents: An Unexpected Effect on Healthy Epithelia

Area of Science:

• Developmental Biology
• Cancer Therapeutics
• Immunology

Background:

• DNA cross-linking agents are widely used as chemotherapeutics in cancer treatment.
• The impact of these agents on normal cells and tissue homeostasis remains poorly understood.
• Non-cell-autonomous effects in tissue response to chemotherapy are an emerging area of research.

Purpose of the Study:

• To investigate the effects of DNA cross-linking agents on normal cells and tissue development.
• To elucidate the mechanisms underlying the observed cellular and tissue responses.
• To understand the role of cell-cell communication in chemotherapy's impact on normal tissues.

Main Methods:

• Utilized DNA cross-linking agents in a model system.
• Analyzed tissue morphology, focusing on epithelial hyperplasia and stem cell populations.
• Investigated inflammasome activation in dermal fibroblasts and its signaling pathways.

Main Results:

• DNA cross-linking agents induced significant epithelial hyperplasia in normal tissues.
• These agents led to stem cell fate mis-specification, altering normal tissue regeneration.
• The effects were mediated in a non-cell-autonomous manner through inflammasome activation in dermal fibroblasts.

Conclusions:

• DNA cross-linking agents can disrupt normal tissue homeostasis by affecting non-cancerous cells.
• Inflammasome activation in fibroblasts is a key mechanism mediating these adverse effects.
• Findings highlight the importance of considering non-cell-autonomous effects in chemotherapy.